PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FTXH vs. ^GSPC
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Performance

FTXH vs. ^GSPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and S&P 500 (^GSPC). The values are adjusted to include any dividend payments, if applicable.

0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
6.45%
12.53%
FTXH
^GSPC

Returns By Period

In the year-to-date period, FTXH achieves a 6.76% return, which is significantly lower than ^GSPC's 25.15% return.


FTXH

YTD

6.76%

1M

-0.59%

6M

6.44%

1Y

16.01%

5Y (annualized)

6.33%

10Y (annualized)

N/A

^GSPC

YTD

25.15%

1M

2.97%

6M

12.53%

1Y

31.00%

5Y (annualized)

13.95%

10Y (annualized)

11.21%

Key characteristics


FTXH^GSPC
Sharpe Ratio1.232.53
Sortino Ratio1.753.39
Omega Ratio1.221.47
Calmar Ratio1.243.65
Martin Ratio4.5416.21
Ulcer Index3.52%1.91%
Daily Std Dev13.01%12.23%
Max Drawdown-32.11%-56.78%
Current Drawdown-4.86%-0.53%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.5

The correlation between FTXH and ^GSPC is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Risk-Adjusted Performance

FTXH vs. ^GSPC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FTXH, currently valued at 1.23, compared to the broader market0.002.004.001.232.53
The chart of Sortino ratio for FTXH, currently valued at 1.75, compared to the broader market-2.000.002.004.006.008.0010.0012.001.753.39
The chart of Omega ratio for FTXH, currently valued at 1.22, compared to the broader market0.501.001.502.002.503.001.221.47
The chart of Calmar ratio for FTXH, currently valued at 1.24, compared to the broader market0.005.0010.0015.001.243.65
The chart of Martin ratio for FTXH, currently valued at 4.54, compared to the broader market0.0020.0040.0060.0080.00100.004.5416.21
FTXH
^GSPC

The current FTXH Sharpe Ratio is 1.23, which is lower than the ^GSPC Sharpe Ratio of 2.53. The chart below compares the historical Sharpe Ratios of FTXH and ^GSPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50JuneJulyAugustSeptemberOctoberNovember
1.23
2.53
FTXH
^GSPC

Drawdowns

FTXH vs. ^GSPC - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum ^GSPC drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for FTXH and ^GSPC. For additional features, visit the drawdowns tool.


-8.00%-6.00%-4.00%-2.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-4.86%
-0.53%
FTXH
^GSPC

Volatility

FTXH vs. ^GSPC - Volatility Comparison

First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a higher volatility of 5.46% compared to S&P 500 (^GSPC) at 3.97%. This indicates that FTXH's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%JuneJulyAugustSeptemberOctoberNovember
5.46%
3.97%
FTXH
^GSPC